The Clinical Significance of CD73 in Cancer

The search for new and effective treatment targets for cancer immunotherapy is an ongoing challenge. Alongside the more established inhibitory immune checkpoints, a novel potential target is CD73. As one of the key enzymes in the purinergic signalling pathway CD73 is responsible for the generation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bach, Niklas, Winzer, Riekje, Tolosa, Eva, Fiedler, Walter, Brauneck, Franziska
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380759/
https://www.ncbi.nlm.nih.gov/pubmed/37511518
http://dx.doi.org/10.3390/ijms241411759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380759/
https://www.ncbi.nlm.nih.gov/pubmed/37511518
http://dx.doi.org/10.3390/ijms241411759

Ejemplares similares